Drugs / Ornidazole
Ornidazole
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 33 trials · 1 met primary | ||||||
| Phase 3 | NCT03491540 | Sep 2018 → Oct 2023 | rectal cancer | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 3 | NCT03475680 | Aug 2018 → Aug 2021 | colon carcinoma | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded |
| Phase 3 | NCT02618720 | May 2016 → Nov 2019 | — | University Hospital, Clermont-Ferrand | Completed | Met primary |
| Phase not applicable2 trials | ||||||
| — | NCT06427863 | Jun 2024 → Dec 2029 expected | constipation disorder | Faming Zhang | Not yet recruiting | No outcome recorded |
| — | NCT06437041 | Jun 2024 → Dec 2029 expected | irritable bowel syndrome | Faming Zhang | Not yet recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06828874 Comparator | May 2023 → Sep 2024 | infectious peritonitis | Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ornidazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06427863 ↗ |
| Known as | NSC-95075 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1449676 ↗ |
| Known as | Ornidazol | ChEMBL registry synonym — accepted as the source's own label CHEMBL1449676 ↗ |
| Known as | RO 7-0207 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1449676 ↗ |
| Known as | Tiberal | ChEMBL registry synonym — accepted as the source's own label CHEMBL1449676 ↗ |
| Modality | Small molecule | — CHEMBL1449676 ↗ |
| Route | Oral | “orally 12 hours before surgery” PMID 36328372 ↗ Nov 2022 |